Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant VWF anticorps (AA 1815-1939)

VWF Reactivité: Humain WB, IHC (f) Hôte: Lapin Monoclonal VWF-1859R unconjugated Recombinant Antibody
N° du produit ABIN6938779
  • Antigène Voir toutes VWF Anticorps
    VWF (Von Willebrand Factor (VWF))
    Type d'anticorp
    Recombinant Antibody
    Épitope
    • 31
    • 16
    • 11
    • 10
    • 7
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1815-1939
    Reactivité
    • 153
    • 37
    • 26
    • 5
    • 5
    • 3
    Humain
    Hôte
    • 88
    • 78
    • 15
    • 7
    Lapin
    Clonalité
    • 96
    • 89
    • 1
    Monoclonal
    Conjugué
    • 91
    • 20
    • 15
    • 7
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp VWF est non-conjugé
    Application
    • 107
    • 98
    • 73
    • 56
    • 52
    • 44
    • 27
    • 18
    • 16
    • 15
    • 14
    • 9
    • 9
    • 8
    • 7
    • 5
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Specificité
    Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.
    Réactivité croisée (Details)
    Human.
    Purification
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogène
    Recombinant fragment of human vWF protein (aa1815-1939) (exact sequence is proprietary)
    Clone
    VWF-1859R
    Isotype
    IgG
    Top Product
    Discover our top product VWF Anticorps primaire
  • Indications d'application

    Known_Application: Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT) (Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: HUVEC cells. Tonsil.

    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Agent conservateur
    Azide free
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Date de péremption
    24 months
  • Antigène
    VWF (Von Willebrand Factor (VWF))
    Autre désignation
    VWF (VWF Produits)
    Synonymes
    anticorps VWF, anticorps si:ch1073-474e24.1, anticorps F8VWF, anticorps VWD, anticorps 6820430P06Rik, anticorps AI551257, anticorps B130011O06Rik, anticorps C630030D09, anticorps von Willebrand factor, anticorps Von Willebrand factor, anticorps VWF, anticorps vwf, anticorps Vwf
    Sujet
    Coagulation Factor VIII, Factor VIII Related Antigen, F8VWF, von Willebrand Antigen 2, von Willebrand Disease (vWD),von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker)
    Cellular localisation: Cytoplasmic
    Poids moléculaire
    250kDa
    ID gène
    7450, 440848
    UniProt
    P04275
Vous êtes ici:
Support technique